Strategic acquisitions Currier’s recent acquisition of Springboard Manufacturing and MOS Plastics indicates accelerated growth, expanded manufacturing capabilities, and an opportunity to cross-sell expanded services such as design engineering, material selection, and end-to-end assembly to a broader medical device customer base.

Board-level expansion New appointments to the Board of Directors suggest a strategic emphasis on governance, scale, and partnerships. This can open doors with healthcare OEMs seeking mature, investor-backed suppliers with strong governance and long-term roadmaps.

Healthcare focus Specialization in medical device components, including cleanroom molding and complex assemblies, positions Currier to upsell high-reliability parts, sterilization management, and regulatory support to OEMs pursuing FDA and global compliance in drug delivery and biologics.

Growth opportunity Revenue in the mid-range of tens of millions and a growing customer base in life sciences and diagnostics present a pathway to expand into adjacent high-margin services such as micro molding, two-shot molding, and post-molding services for next-generation devices.

Market momentum Industry trends toward connected, minimally invasive therapies and advanced drug delivery align with Currier’s capabilities. This creates demand for turnkey manufacturing partnerships from concept through scale, offering cross-sell of design for manufacturability, regulatory support, and sterilization and kitting services.